Crossmark

Formulation and in vitro/in vivo characterization of a fixed-dose combination tablet of dapagliflozin and rosuvastatin

Published Online: 2024-07-05

Published Print: 2025-01

Authors

An, Jieun

Kim, Dohyun

Kim, Sungjun

Kim, Hyun Jun

Na, Dong Hee https://orcid.org/0000-0001-9313-0127
License Information

Text and Data Mining valid from 2024-07-05

Version of Record valid from 2024-07-05
More Information

Article History

Received: 29 April 2024

Accepted: 18 June 2024

First Online: 5 July 2024

Declarations

:

: The animal studies were performed after receiving approval of the Institutional Animal Care and Use Committee (IACUC) in DT&CRO (IACUC approval No. DT&CRO-IACUC-200104).

: All authors (J. An, D. Kim, S. Kim, H.J. Kim, and D.H. Na) declare that they have no conflict of interest.

Document is current